Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancersMohamed E Salem, Alberto Puccini, Elizabeth Mauer, et al.
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Journal of the American College of Surgeons|March 15, 2022
Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver MetastasesYujiro Nishioka, Yun Shin Chun, Michael J Overman, et al.
Frontiers in Oncology|October 10, 2022
Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenograftsPreeti Kanikarla Marie, Alexey V Sorokin, Lea A Bitner, et al.
British Journal of Cancer|June 9, 2016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancerMichael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, et al.
British Journal of Cancer|August 1, 2020
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancerKanwal Raghav, John P Shen, Alexandre A Jácome, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Annals of Surgical Oncology|October 6, 2017
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal AdenocarcinomaSuguru Yamashita, Michael J Overman, Huamin Wang, et al.
Pageof 22